| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ANI PHARMACEUTICALS INC COM | 395,000 | 13,296,000 | 19.53% | ||
| 2 | Albany Molecular | 402,400 | 6,153,000 | 9.04% | ||
| 3 | PFIZER INC | 175,000 | 5,187,000 | 7.62% | ||
| 4 | SPDR S&P 500 ETF TR | 25,000 | 5,138,000 | 7.55% | Put | |
| 5 | DEPOMED INC | 350,000 | 4,876,000 | 7.16% | ||
| 6 | QUEST DIAGNOSTICS INC | 66,208 | 4,731,000 | 6.95% | ||
| 7 | CRYOLIFE INC | 400,000 | 4,300,000 | 6.32% | ||
| 8 | QLT INC | 2,157,200 | 4,293,000 | 6.31% | ||
| 9 | ALLERGAN PLC | 10,000 | 2,681,000 | 3.94% | ||
| 10 | PROSHARES TR | 50,000 | 2,178,000 | 3.20% | Call | |
| 11 | GLAXOSMITHKLINE PLC | 50,000 | 2,028,000 | 2.98% | Call | |
| 12 | EAGLE PHARMACEUTICALS INC COM | 50,000 | 2,025,000 | 2.97% | Call | |
| 13 | PROSHARES ULTRASHORT RUSSELL2000 | 50,000 | 1,939,000 | 2.85% | Call | |
| 14 | DEPOMED INC | 100,000 | 1,393,000 | 2.05% | Call | |
| 15 | PROSHARES ULTRASHORT RUSSELL2000 | 25,000 | 969,000 | 1.42% | ||
| 16 | LANNET INC COM NEW | 50,000 | 897,000 | 1.32% | Call | |
| 17 | Albany Molecular | 50,000 | 765,000 | 1.12% | Call | |
| 18 | CYTOKINETICS INC | 100,000 | 705,000 | 1.04% | ||
| 19 | ARALEZ PHARMACEUTICALS INC | 175,000 | 621,000 | 0.91% | Call | |
| 20 | SAGENT PHARMACEUTICALS INC | 50,000 | 609,000 | 0.89% | ||
| 21 | ACADIA PHARMACEUTICALS INC COM | 20,000 | 559,000 | 0.82% | Put | |
| 22 | CRYOLIFE INC | 50,000 | 538,000 | 0.79% | Call | |
| 23 | SAGENT PHARMACEUTICALS INC | 35,000 | 426,000 | 0.63% | Call | |
| 24 | FIBROCELL SCIENCE INC | 147,769 | 369,000 | 0.54% | ||
| 25 | ARALEZ PHARMACEUTICALS INC | 100,000 | 355,000 | 0.52% | ||
| 26 | ZOGENIX INC | 31,850 | 294,000 | 0.43% | ||
| 27 | SORRENTO THERAPEUTICS INC COM NEW | 50,000 | 269,000 | 0.40% | ||
| 28 | Apricus Biosciences, Inc. | 440,000 | 256,000 | 0.38% | ||
| 29 | QLT INC | 100,000 | 147,000 | 0.22% | Call | |
| 30 | Sunesis Pharmaceuticals I | 150,000 | 81,000 | 0.12% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-16-013178, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
